| The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan S Watanabe, T Ohnishi, A Yuasa, H Kiyota, S Iwata, M Kaku, A Watanabe, ... Journal of Infection and Chemotherapy 23 (8), 503-511, 2017 | 32 | 2017 |
| Use of productivity loss/gain in cost-effectiveness analyses for drugs: a systematic review A Yuasa, N Yonemoto, M LoPresti, S Ikeda Pharmacoeconomics 39, 81-97, 2021 | 24 | 2021 |
| Optimal treatment for complicated intra-abdominal infections in the era of antibiotic resistance: a systematic review and meta-analysis of the efficacy and safety of combined … H Mikamo, A Yuasa, K Wada, B Crawford, N Sugimoto Open Forum Infectious Diseases 3 (3), ofw143, 2016 | 19 | 2016 |
| Patient preferences for growth hormone treatment in Japanese children T Tanaka, T Sato, A Yuasa, T Akiyama, A Tawseef Pediatrics International 63 (10), 1185-1191, 2021 | 14 | 2021 |
| Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review A Yuasa, N Yonemoto, M LoPresti, S Ikeda Expert Review of Pharmacoeconomics & Outcomes Research 21 (2), 235-245, 2021 | 12 | 2021 |
| Health‐related quality of life in patients with alopecia areata: Results of a Japanese survey with norm‐based comparisons T Ito, K Kamei, A Yuasa, F Matsumoto, Y Hoshi, M Okada, S Noto The Journal of Dermatology 49 (6), 584-593, 2022 | 11 | 2022 |
| Investigation of factors considered by health technology assessment agencies in eight countries A Yuasa, N Yonemoto, S Demiya, C Foellscher, S Ikeda PharmacoEconomics-Open 5, 57-69, 2021 | 11 | 2021 |
| Treatment procedures and associated medical costs of methicillin-resistant Staphylococcus aureus infection in Japan: A retrospective analysis using a database of … A Yuasa, T Murata, K Imai, Y Yamamoto, Y Fujimoto SAGE open medicine 7, 2050312119871181, 2019 | 10 | 2019 |
| A systematic literature review of economic evaluations and cost studies of the treatment of Psoriasis, atopic dermatitis, and chronic Urticaria A Igarashi, A Yuasa, N Yonemoto, K Kamei, M LoPresti, T Murofushi, ... Dermatology and therapy 12 (8), 1729-1751, 2022 | 8 | 2022 |
| Estimating the economic and clinical value of reducing antimicrobial resistance to three gram-negative pathogens in Japan T Matsumoto, O Darlington, R Miller, J Gordon, P McEwan, T Ohashi, ... Journal of Health Economics and Outcomes Research 8 (2), 64, 2021 | 6 | 2021 |
| estimating the economic and clinical value of introducing ceftazidime/avibactam into antimicrobial practice in Japan: a dynamic modelling study T Matsumoto, A Yuasa, R Miller, C Pritchard, T Ohashi, A Taie, J Gordon PharmacoEconomics-Open 7 (1), 65-76, 2023 | 5 | 2023 |
| Cost-effectiveness analysis of tofacitinib compared with biologics in biologic-naïve patients with moderate-to-severe ulcerative colitis in Japan T Kobayashi, M Hoshi, A Yuasa, S Arai, M Ikeda, H Matsuda, SW Kim, ... Pharmacoeconomics 41 (5), 589-604, 2023 | 3 | 2023 |
| Systematic literature review of the use of productivity losses/gains in cost-effectiveness analyses of immune-mediated disorders A Yuasa, N Yonemoto, K Kamei, T Murofushi, M LoPresti, A Taneja, ... Advances in Therapy 39 (12), 5327-5350, 2022 | 3 | 2022 |
| Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data M Ohyama, K Kamei, A Yuasa, P Anderson, G Milligan, M Sakaki‐Yumoto The Journal of Dermatology 50 (10), 1246-1254, 2023 | 2 | 2023 |
| An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan M Sugai, A Yuasa, RL Miller, V Vasilopoulos, H Kurosu, A Taie, ... Infectious Diseases and Therapy 12 (6), 1695-1713, 2023 | 2 | 2023 |
| Cost-effectiveness analysis of the treatment strategies with or without opioid medications in surgery-eligible patients with osteoarthritis in Japan T Takura, A Yuasa, N Yonemoto, S Demiya, H Matsuda, N Ebata, K Fujii, ... PharmacoEconomics-Open 6 (1), 33-45, 2022 | 1 | 2022 |
| Outcome Research to Investigate The Actual Status of Mrsa Infection And Usage of Anti-Mrsa Drugs In Real Clinical Settings In Japan: A Retrospective Database Study A Yuasa, Y Ii, Y Yamamoto, S Kitazaki, K Saito, Y Fujimoto Value in Health 18 (7), A576, 2015 | 1 | 2015 |
| Cost‐effectiveness analysis of abrocitinib compared with standard of care in adult moderate‐to‐severe atopic dermatitis in Japan A Tanaka, A Yuasa, K Kamei, M Nagano, T Murofushi, A Bjerke, ... The Journal of Dermatology 51 (6), 759-771, 2024 | | 2024 |
| Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis T Matsumoto, A Yuasa, H Matsuda, D Ainiwaer, N Yonemoto Infectious Diseases and Therapy, 1-21, 2024 | | 2024 |
| Treatment Patterns in Metastatic Bladder Cancer in Japan: Results of the CancerMPact® Survey 2020 AP A Bueno, O Clark, M Turnure, ES Moreira, A Yuasa, S Sugiyama, ... Future Oncology 20 (10), 603-611, 2024 | | 2024 |
